Paradigm Medical Industries Inc
OTC:PDMI
Relative Value
There is not enough data to reliably calculate the relative value of PDMI.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
PDMI Competitors Multiples
Paradigm Medical Industries Inc Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Paradigm Medical Industries Inc
OTC:PDMI
|
3.2k USD | 0 | -0 | 0 | 0 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
191.5B USD | 4.3 | 29.4 | 16.8 | 23.1 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
173.8B USD | 17.3 | 61 | 46.3 | 56.9 | |
| US |
|
Stryker Corp
NYSE:SYK
|
138B USD | 5.5 | 42.6 | 21.7 | 26.2 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
115.8B USD | 3.2 | 25 | 13.7 | 20 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
104.4B USD | 5.2 | 36.2 | 21.2 | 28.5 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
45.2B EUR | 2 | 21.4 | 11.9 | 16.7 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
49.4B USD | 8.2 | 46.1 | 25.4 | 27.8 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
48.2B USD | 11.3 | 45.9 | 32.6 | 36.1 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
47B USD | 2.1 | 26.8 | 10.4 | 17.6 | |
| US |
|
Resmed Inc
NYSE:RMD
|
36B USD | 6.7 | 24.3 | 17.1 | 19 |